CLINICAL_TRIALS
trial_result
· 2019-01-28
Clinical Trial Update: Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma [Phase 2]
Summary
Phase 2 trial evaluating dupilumab effects on airway inflammation in asthma patients has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2019-01-28